Alignment Healthcare Inc. (NASDAQ:ALHC) stock’s Relative Strength Index (RSI) is 63.49, with weekly volatility at 6.97% and ATR at 1.64. The ALHC stock’s 52-week price range has touched low of $16.32 and a $28.59 high. Its shares traded lower over the last trading session, losing -1.50% on 06/17/21. The shares fell to a low of $26.23 before closing at $26.35. Intraday shares traded counted 0.48 million, which was 4.66% higher than its 30-day average trading volume of 503.74K. ALHC’s previous close was $26.75 while the outstanding shares total 187.27M.
Investors have identified the Healthcare Plans company Alignment Healthcare Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $4.95 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Alignment Healthcare Inc. (ALHC) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 604.65 million total, with 169.79 million as their total liabilities.
ALHC were able to record -42.55 million as free cash flow during the 09/01/2021 quarter of the year, this saw their quarterly net cash flow reduce by 321.11 million. In cash movements, the company had a total of -38.11 million as operating cash flow.
Potential earnings growth for Alignment Healthcare Inc. (ALHC)
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 251.09 million trying to sell their products during the last quarter, with the result yielding a gross income of 15.99 million. This allows shareholders to hold on to 187.27M with the recently reported earning now reading -0.37 cents per share. This is a figure that compared to analyst’s prediction for their 09/01/2021 (-0.37 cents a share).
Having a look at the company’s valuation, the company is expected to record -0.45 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on ALHC sounds very interesting.
Is the stock of ALHC attractive?
In related news, Director, WARBURG PINCUS LLC sold 716,624 shares of the company’s stock in a transaction that recorded on Apr 06. The sale was performed at an average price of 16.83, for a total value of 12,060,782. As the sale deal closes, the Director, WARBURG PINCUS LLC now sold 716,624 shares of the company’s stock, valued at 12,060,782. Also, Chief Legal Officer, Foster Michael Curtis sold 50,843 shares of the company’s stock in a deal that was recorded on Apr 06. The shares were price at an average price of 16.83 per share, with a total market value of 855,688. Following this completion of acquisition, the Chief Financial Officer, Freeman Robert Thomas now holds 38,919 shares of the company’s stock, valued at 655,007. In the last 6 months, insiders have changed their ownership in shares of company stock by 4.60%.
3 out of 6 analysts covering the stock have rated it a Buy, while 2 have maintained a Hold recommendation on Alignment Healthcare Inc.. 0 analysts has assigned a Sell rating on the ALHC stock. The 12-month mean consensus price target for the company’s shares has been set at $29.80.